- By Shreyansh Mangla
- Mon, 14 Jul 2025 07:02 PM (IST)
- Source:JND
The Anthem Biosciences IPO, though experiencing a cautious start, is now open for public subscription. As of 5PM IST on July 14, 2025, the IPO was subscribed 0.73 times in total.
Anthem Biosciences IPO: Who's Handling the IPO?
JM Financial Limited, Citigroup Global Markets India, J P Morgan India, and Nomura Financial Advisory and Securities (India) Pvt Ltd are the Book Running Lead Managers (BRLMs) for this share sale. KFin Technologies Limited is the registrar for the issue.
What Anthem Biosciences Does and How It Makes Money
Anthem Biosciences, established in 2006, is a research-focused Contract Research, Development, and Manufacturing Organization (CRDMO). It offers end-to-end services for creating and producing drugs, serving a diverse global client base ranging from small biotech firms to large pharmaceutical companies. They specialize in manufacturing special ingredients for medicines, including probiotics, enzymes, peptides, and biosimilars.
ALSO READ: Retail Inflation Hits Low Of 2.1% In June, Marking First Such Downfall In Six Years
Anthem Biosciences IPO: Financial Health (Year ending March 2025)
Revenue: Rs 1,930.29 crore
Profit (PAT): Rs 451.26 crore
Net Profit Margin: 23.38 per cent
Growth: Between March 2024 and March 2025, their revenue grew by 30.16 per cent and profits by 22.86 per cent.
Anthem Biosciences: Where Does the IPO Money Go?
This IPO is entirely an "Offer for Sale (OFS)". This means the company will not receive any proceeds from the share sale. Instead, the entire amount raised will go to the existing shareholders (promoters and other investors) who are selling their shares.
Key Details for Buying Shares
Anthem Biosciences Share Price Band: Rs 540 to Rs 570 per share.
Anthem Biosciences IPO Minimum Bid Quantity: 26 shares, costing a minimum of Rs 14,040 at the lower price band. Bids must be in multiples of 26 shares (e.g., 26, 52, 78 shares, etc.).
Anthem Biosciences IPO Open and Close Dates: The IPO opened on July 14, 2025, and will continue till July 16, 2025.
Anthem Biosciences IPO Allotment Date: The finalisation of share allotment is expected around July 17, 2025 (Thursday).
Anthem Biosciences IPO Listing Date: The shares are expected to be listed and begin trading on the stock market around July 21, 2025 (Monday) on both the BSE and NSE exchanges.
These dates are crucial for anyone planning to invest, as they tell you exactly when you can apply, when you'll know if you got shares, and when you can start trading them.
ALSO READ: Rupee Sinks To 86.02 Against USD Amid Global Oil Price Increase And Foreign Outflows
What's the Grey Market Premium (GMP)?
The Grey Market Premium (GMP) is an unofficial estimate of how much extra profit you might make on the day the shares start trading. As of today, July 14, 2025, the GMP for Anthem Biosciences is Rs 100.
What this means: If the shares are allotted at the upper price band of Rs 570, the GMP suggests they might list around Rs 670 (Rs 570 + Rs 100).
Potential Gain: This would imply a possible listing gain of approximately 17.54% per share.
GMP provides investors with a rough idea of the demand and excitement for an IPO before it officially lists. A higher GMP often suggests a better chance of a quick profit on listing day, but remember, it's just an estimate and not guaranteed.
